HIV drug combo fails to trim fat in early trial
Disease control
Terminated
This study tested whether switching to a two-drug combination (raltegravir plus maraviroc) could reduce belly fat in people with well-controlled HIV. It included 48 adults who had been on stable HIV therapy for years and had excess belly fat. The trial was stopped early, so the r…
Phase: PHASE2 • Sponsor: ANRS, Emerging Infectious Diseases • Aim: Disease control
Last updated May 13, 2026 16:03 UTC